CN105362839A - 一种治疗妇科炎症的中药组合物 - Google Patents
一种治疗妇科炎症的中药组合物 Download PDFInfo
- Publication number
- CN105362839A CN105362839A CN201510854513.3A CN201510854513A CN105362839A CN 105362839 A CN105362839 A CN 105362839A CN 201510854513 A CN201510854513 A CN 201510854513A CN 105362839 A CN105362839 A CN 105362839A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- blood
- fructus
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 68
- 206010061218 Inflammation Diseases 0.000 title claims abstract description 17
- 230000004054 inflammatory process Effects 0.000 title claims abstract description 16
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 claims abstract description 35
- 230000001684 chronic effect Effects 0.000 claims abstract description 24
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 8
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000829 suppository Substances 0.000 claims description 20
- 241000746375 Andrographis Species 0.000 claims description 9
- 241001649190 Campsis Species 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 7
- 239000008280 blood Substances 0.000 abstract description 87
- 210000004369 blood Anatomy 0.000 abstract description 86
- 201000010099 disease Diseases 0.000 abstract description 40
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 40
- 230000000694 effects Effects 0.000 abstract description 32
- 230000008901 benefit Effects 0.000 abstract description 10
- 208000025661 ovarian cyst Diseases 0.000 abstract description 5
- 206010046914 Vaginal infection Diseases 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 201000008100 Vaginitis Diseases 0.000 abstract description 3
- 230000003213 activating effect Effects 0.000 abstract description 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241001546929 Campsis grandiflora Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000006028 Sambucus nigra Species 0.000 abstract 1
- 235000003142 Sambucus nigra Nutrition 0.000 abstract 1
- 241000246044 Sophora flavescens Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 235000008995 european elder Nutrition 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 31
- 208000002193 Pain Diseases 0.000 description 27
- 230000036407 pain Effects 0.000 description 25
- 230000001737 promoting effect Effects 0.000 description 22
- 230000017531 blood circulation Effects 0.000 description 19
- 238000010438 heat treatment Methods 0.000 description 18
- 231100000614 poison Toxicity 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 17
- 210000004291 uterus Anatomy 0.000 description 17
- 239000000758 substrate Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 210000003734 kidney Anatomy 0.000 description 14
- 239000000843 powder Substances 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 239000003440 toxic substance Substances 0.000 description 13
- 208000019255 Menstrual disease Diseases 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- 238000001816 cooling Methods 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 230000001717 pathogenic effect Effects 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 description 10
- 210000001015 abdomen Anatomy 0.000 description 10
- 239000000706 filtrate Substances 0.000 description 10
- 244000052769 pathogen Species 0.000 description 10
- 208000026435 phlegm Diseases 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 206010013935 Dysmenorrhoea Diseases 0.000 description 9
- 208000003251 Pruritus Diseases 0.000 description 9
- 230000006378 damage Effects 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 8
- 208000005171 Dysmenorrhea Diseases 0.000 description 8
- 208000033809 Suppuration Diseases 0.000 description 8
- 230000001154 acute effect Effects 0.000 description 8
- 230000005906 menstruation Effects 0.000 description 8
- 201000000736 Amenorrhea Diseases 0.000 description 7
- 206010001928 Amenorrhoea Diseases 0.000 description 7
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 7
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 7
- 231100000540 amenorrhea Toxicity 0.000 description 7
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 7
- 229960003321 baicalin Drugs 0.000 description 7
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 7
- 208000001848 dysentery Diseases 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 210000003101 oviduct Anatomy 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 238000007493 shaping process Methods 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 229920000742 Cotton Polymers 0.000 description 6
- WNGSUWLDMZFYNZ-UHFFFAOYSA-N Leonurine Chemical compound COC1=CC(C(=O)OCCCCN=C(N)N)=CC(OC)=C1O WNGSUWLDMZFYNZ-UHFFFAOYSA-N 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 208000025747 Rheumatic disease Diseases 0.000 description 6
- 210000000481 breast Anatomy 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000002398 materia medica Substances 0.000 description 6
- 230000001047 pyretic effect Effects 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 230000000552 rheumatic effect Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 208000021267 infertility disease Diseases 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 229960000502 poloxamer Drugs 0.000 description 4
- 229920001983 poloxamer Polymers 0.000 description 4
- 230000000306 recurrent effect Effects 0.000 description 4
- 208000005687 scabies Diseases 0.000 description 4
- 238000007873 sieving Methods 0.000 description 4
- 206010040872 skin infection Diseases 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 210000001215 vagina Anatomy 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000762515 Hydrosalpinx Species 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000007893 Salpingitis Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 230000001076 estrogenic effect Effects 0.000 description 3
- 238000002481 ethanol extraction Methods 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 208000030843 hydrosalpinx Diseases 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000013618 particulate matter Substances 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 230000008016 vaporization Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 206010034240 Pelvic congestion Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010037714 Quadriplegia Diseases 0.000 description 2
- 208000004680 Rectal Fistula Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000031737 Tissue Adhesions Diseases 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 206010002156 anal fistula Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000010410 dusting Methods 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000013521 mastic Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 208000007106 menorrhagia Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 208000010553 multiple abscesses Diseases 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000003119 painkilling effect Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000001256 steam distillation Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 238000011121 vaginal smear Methods 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 244000118350 Andrographis paniculata Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010050697 Fallopian tube cyst Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000117280 Naematelia aurantialba Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 241001480046 Trichophyton schoenleinii Species 0.000 description 1
- 206010054824 Tubo-ovarian abscess Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 210000001142 back Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000009989 contractile response Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000008929 jingui shenqi Substances 0.000 description 1
- 230000036445 liquid secretion Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- -1 quick Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 230000000192 social effect Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 231100000563 toxic property Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗妇科炎症的中药组合物,各种原料的重量份数为:丹参10~15份,穿心莲10~15份,鸡血藤10~15份,益母草10~15份,桃仁10~15份,败酱草10~15份,大血藤10~15份,赤芍10~15份,凌霄花10~15份,接骨木10~15份,蒲公英10~15份,黄芩10~15份,地肤子10~15份,青黛10~20份,蛇床子10~20份,桑白皮10~20份,山茱萸10~20份,覆盆子10~20份,白芍10~20份,香附10~20份,白芷10~20份,苦参10~20份,土茯苓10~20份。本发明具有活血化瘀、清利湿热、直达病灶的功效,用于慢性盆腔炎、慢性附件炎、卵巢囊肿、阴道炎等常见病的治疗,效果显著。本发明具有溶解快、释药迅速的优点,达到快速缓解症状目的。
Description
技术领域
本发明涉及含有来源于植物、动物或矿物原料的医用配制品,特别涉及一种治疗妇科炎症的中药组合物。
背景技术
女性盆腔炎是指内生殖器(包括子宫、输卵管、宫旁结缔组织及盆腔腹膜)的炎症,既可局限于女性身体的某个部位,也可涉及整个内生殖器。如果病变仅局限于输卵管及卵巢时,通常称为附件炎。根据女性盆腔炎的病变发展过程,临床将其分为急性盆腔炎和慢性盆腔炎两种,祖国医学中,此病属于腹痛、热入血室、带下、不孕等范畴。
慢性盆腔炎包括慢性附件炎和慢性盆腔结缔组织炎。前者常表现为输卵管壁增厚变硬,粘膜层有炎性渗出物,输卵管发生粘连,使管腔阻塞,甚至卵巢同时受累并与输卵管穿通,形成输卵管卵巢囊肿或脓肿。后者则因急性炎症未能彻底治愈而发展成慢性,由于组织充血、水肿,继而又出现纤维组织增生、变硬,其炎症也可能呈扇形象外扩散直达盆腔,子宫因此常被固定,这种慢性炎症病情顽固,不易根治。
慢性盆腔炎主要表现为下腹坠胀疼痛,腰股疼痛,有时伴有肛门坠胀不适,常在劳累、性交后、排便时及月经前后加重,另外,还可能伴有尿频、白带增多、月经异常、痛经及不孕等症状。妇检时,如果是附件炎,可在子宫的一侧或两侧呈增粗的条索状物或片块状物,并伴有压痛;如已形成输卵管积水或输卵管囊肿,则可触及囊性包块;若是盆腔结缔组织炎,子宫两侧可呈片状增厚并有不同程度的压痛。
慢性盆腔炎是妇科常见病、难治病,有缠绵不愈、易于复发的特点,是国内外妇科治疗中的一大难题。慢性盆腔炎多为急性盆腔炎治疗不彻底,患者遇感冒、劳累过度等导致抗病力低下,病源菌又活跃起来致盆腔炎症复发,亦有部分患者并无急性炎症史,因起病缓慢,忽视治疗所致。其病理改变为盆腔内炎性渗出、器官粘连、局部组织瘢痕增生,子宫固定不动。盆腔瘀血则月经量多,卵巢功能损害则月经失调,输卵管粘连则不孕,输卵管积水则卵巢囊肿。
祖国医学认为该病多由经行产后胞脉空虚,外感湿邪热毒内侵胞宫;或脾肾虚损,水湿内停日久化热;或过食肥甘厚味,内生湿热,下注胞宫;或肝郁气滞化火,痰火流注胞宫,致盆腔脏器内膜气血运行不畅,湿邪热毒、痰火瘀血互结,化腐成脓,损害盆腔组织。由于失治或误治,致反复发作,迁延不愈,器官组织粘连、增生而成瘕包块。该病虚实夹杂、湿热痰瘀相互为患,脾肾虚损是其本,湿热痰瘀阻滞是其标。
我国及世界范围内,妇女慢性盆腔炎的发病率均呈上升趋势,严重损害了广大妇女的身心健康,给生活带来不尽的麻烦,而治疗这一顽疾一直没有有效的方法。慢性盆腔炎的病人大都反复发作,缠绵难愈,影响生活质量。多数病人虽多方求治,但一般都效果不佳,导致焦虑、抑郁,进而更进一步加重病情,严重影响工作及生活质量。
发明内容
本发明所要解决的技术问题在于,慢性盆腔炎,附件炎是妇科常见病,多为急性盆腔炎未能恰当彻底治疗或患者体质较差,病程迁延所致,此病情较顽固。目前用于治疗该病的药有西药,也有中药。但这些药大都疗效不显著,只是起暂时缓解病情的作用,而不能达到彻底治愈的目的,只能维持或减轻病情,不能根治。因此使许多患者延误治疗或久治不愈反复发作,致使患者月经失调,导致不育(不孕症)。本发明在传统医学的基础上结合多年临床经验,采用现代加工方法精心研制而成。本发明对原料药品的各有效成分科学配伍,能直达病灶,且见效快、副作用小、抑菌性强的制剂,能有效解除患者的痛苦,达到祛除疾病的目的。
为解决上述技术问题,本发明提供了一种治疗妇科炎症的中药组合物,所述中药组合物中各种原料的重量份数为:丹参10~15份,穿心莲10~15份,鸡血藤10~15份,益母草10~15份,桃仁10~15份,败酱草10~15份,大血藤10~15份,赤芍10~15份,凌霄花10~15份,接骨木10~15份,蒲公英10~15份,黄芩10~15份,地肤子10~15份,青黛10~20份,蛇床子10~20份,桑白皮10~20份,山茱萸10~20份,覆盆子10~20份,白芍10~20份,香附10~20份,白芷10~20份,苦参10~20份,土茯苓10~20份。
所述治疗妇科炎症的中药组合物,其各种原料的重量份数还可以为:丹参10~15份,穿心莲10~15份,鸡血藤10~15份,益母草10~15份,桃仁10~15份,败酱草10~15份,大血藤10~15份,赤芍10~15份,凌霄花10~15份,接骨木10~15份,蒲公英10~15份,黄芩10~15份,地肤子10~15份,青黛10~15份,蛇床子10~15份,桑白皮10~15份,山茱萸10~15份,覆盆子10~15份,白芍10~15份,香附10~15份,白芷10~15份,苦参10~15份,土茯芩10~15份。
为解决上述技术问题,本发明还提供一种治疗妇科炎症的中药组合物的制备方法,其制备步骤包括:将所述原料药除白芷与香附外,其余加水浸泡30分钟至1小时,加热煮沸30~40分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30~40分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸30~40分钟,过滤;将三次滤液合在一起,加热浓缩至膏状,再将白芷、香附用水蒸汽蒸馏法提取,得结晶物,混在上述得到的药膏里;选取基质50℃~60℃加热融化,加入上述得到的药膏冷却定型制成类弹头状栓剂,紫外线杀毒。
所述治疗妇科炎症的中药组合物的制备方法,其所述栓剂所用的基质选自:半合成脂肪酸甘油酯、泊洛沙姆、聚乙二醇、羊毛脂中的一种或多种;所述基质在温度50℃~60℃条件下加热融化,加入所述制备方法制得的药物膏体,水浴搅拌均匀,混合成粘稠的液体,灌注在塑料定型管内,插入棉栓,冷却定型制成子弹头状栓剂;所述棉栓为尾部带有棉线的棉栓。
为解决上述技术问题,本发明再提供一种治疗妇科炎症的中药组合物的制备方法,其制备过程进一步包括:
a.将所述原料药除白芷和香附外放入粉碎机粉碎后过筛,
b.将过筛后剩下的颗粒物放入乙醇中加热回流提取2次;
c.再取上述乙醇提取后的药渣,加水加热回流提取2次;
d.将香附与白芷蒸馏汽化得结晶,加入上述两种提取液中,基质调和罐装定型,紫外线杀毒。
所述步骤a中,可以将所述原料药除白芷与香附外放入粉碎机粉碎后过100目细筛,使能通过100目筛的细粉量在达到30%,收集通过100目筛的原料细粉备用。
所述步骤b中,可以将过筛后剩下的颗粒物放入乙醇中加热回流提取2次,每次1~2小时,将2次提取液合并静置;
所述步骤c中,可以将上述乙醇提取过的药渣加10倍量水加热回流提取2次,每次1~2小时,将2次提取液合并静置。
所述步骤d中,可以将香附与白芷蒸馏汽化得结晶,干燥成粉末;再将上述两种提取液合并,减压浓缩相对密度为80℃时1.37的滤液,回收乙醇,将所得滤液调整比重到1.06,加入过筛的细粉和结晶粉末后搅匀,倒入基质中,50℃~60℃加热融化,冷却定型制成类弹头状栓剂,所述粉剂中成药与基质的配比为1∶2~1∶4;所述棉栓为尾部带有棉线的棉栓。
本发明采用药栓和棉栓一体工艺,弥补了普通栓剂的不足,普通栓剂不能有效送达到阴道的深处。由于阴道的自净作用,当有异物存在时,会增加液体分泌,在短时间内将药物排除体外,既降低了疗效,又延长了疗程,增加费用又污染内衣裤。而本发明克服这一技术难题,制成的栓剂可充分发挥药物疗效,具有安全性好,可行性好的优点,能直达病灶,达到祛病目的。
与现有技术相比,本技术具有给药方便,药剂易于制造,成本低廉等优点。本发明具有活血化瘀、清利湿热的功效,用于气滞蕴结之盆腔炎,症见带下量多,下腹疼痛等症,同时适用于慢性盆腔炎、慢性附件炎、卵巢囊肿、阴道炎等常见病的治疗,效果显著。该药具有溶解快、释药迅速的优点,达到快速缓解症状和治疗的目的。
具体实施方式
盆腔炎,相当于祖国医学中的“带下病”、“月经不调”、“痛经”、“症瘕”等疾病范畴中。该疾病的发病原因多为分娩、流产、妇科手术或月经后,血窦开放,有所不慎,湿热邪毒乘虚而入,若邪气盛正气亦盛,则病情来势较猛,若邪盛正虚,则急性炎症状况不甚明显。多因失治误治而转为慢性阶段。临床以慢性盆腔炎者最多见。其病机为湿浊、湿热、寒湿邪毒蕴结瘀滞在胞宫、胞脉,以致经络闭阻不通,气机不畅,气血凝滞而成。因而急性期要用大剂量的清热解毒,利湿活血化瘀之剂。慢性期是由急性期迁延而来,由于经络瘀滞日久,所以要以活血化瘀,清热、利湿为主,酌加益气之品,还要辨清湿浊的性质,灵活地加入健脾利湿或清热解毒、温阳化湿的药物,不可墨守常规。故宜健脾益肾祛痰湿、清热解毒疏肝、活血化瘀散结为基本治法。
慢性盆腔炎是妇科常见病、难治病,有缠绵不愈、易于复发的特点,是国内外妇科治疗中的一大难题。慢性盆腔炎多为急性盆腔炎治疗不彻底,患者遇感冒、劳累过度等导致抗病力低下,病源菌又活跃起来致盆腔炎症复发,亦有部分患者并无急性炎症史,因起病缓慢,忽视治疗所致。其病理改变为盆腔内炎性渗出、器官粘连、局部组织瘢痕增生,子宫固定不动。盆腔瘀血则月经量多,卵巢功能损害则月经失调,输卵管粘连则不孕,输卵管积水则卵巢囊肿。
祖国医学认为该病多由经行产后胞脉空虚,外感湿邪热毒内侵胞宫;或脾肾虚损,水湿内停日久化热;或过食肥甘厚味,内生湿热,下注胞宫;或肝郁气滞化火,痰火流注胞宫,致盆腔脏器内膜气血运行不畅,湿邪热毒、痰火瘀血互结,化腐成脓,损害盆腔组织。由于失治或误治,致反复发作,迁延不愈,器官组织粘连、增生而成瘕包块。该病虚实夹杂、湿热痰瘀相互为患,脾肾虚损是其本,湿热痰瘀阻滞是其标。
本发明的目的,就是针对妇科疾病中盆腔炎的药物的疗效均不理想,见效较慢,对人体副作用大,对妇女身体危害较大,且易反复的缺点,发明生产一种见效快、副作用小、抑菌性强的药物,以解除患者的痛苦。本发明继承祖国的医学遗产,将中华医药发扬光大,利用满山遍野的中草药资源优势,研制一种特效、安全、方便、价廉、纯天然的中药制剂,用以治疗妇女的各种盆腔炎等常见妇科病,多发病,弥补西药毒副作用大,对妇女身体危害深等缺陷。本发明制备工艺简单,药物原料价格低廉,疗效好,能达到比较好的社会效果及经济利益。本发明具有活血化瘀、清利湿热的功效,用于气滞蕴结之盆腔炎,症见带下量多,下腹疼痛等症,同时适用于慢性盆腔炎、慢性附件炎、卵巢囊肿、阴道炎等常见病的治疗,效果显著。该药具有溶解快、释药迅速的优点,达到快速缓解症状和治疗的目的。
本发明内服中药选用凌霄花,之甘凉,清热利湿,消炎解毒使之下焦胞宫郁热得清,水湿得利,热毒得除;《本草纲目》云:“败酱,善排脓破血,故仲景治痈,及古方妇人科皆用之,乃至易得之物,而后人不知用,盖未遇识者耳。”实验证明败酱草、大血藤能增强网状细胞和白细胞的吞噬能力,提高机体抗感染力,促进抗体形成及提高血清中溶菌酶水平,从而达到抗菌消炎的目的。而以桃仁,丹参活血祛瘀,补血调经,从而共成清热利湿,祛瘀止痛,当归,穿心莲补而不燥,利于温补之功效。赤芍能清血分实热,散瘀血留滞实乃治疗妇科内淤的良药。根据中医“久病多虚、久病多瘀”的理论,治疗以扶正祛邪为原则,实在所治疗妇女痛经带下、盆腔、阴道、附件等各种炎症之良方。
桃仁苦,甘,平为血瘀血闭之专药。苦以泄滞血,甘以生新血。《药品化义》:桃仁,味苦能泻血热,体润能滋肠燥。若连皮研碎多用,走肝经,主破蓄血,逐月水,及遍身疼痛,四肢木痹,左半身不遂,左足痛甚者,以其舒经活血行血,有去瘀生新之功,若去皮捣烂少用,入大肠,治血枯便闭,血燥便难,以其濡润凉血和血,有开结通滞之力。
丹参苦,微寒。归心、肝经。祛瘀止痛,活血通经,清心除烦。用于月经不调,经闭痛经,症瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠。用于胸肋胁痛,风湿痹痛,症瘕结块,疮疡肿痛,跌仆伤痛,月经不调,经闭痛经,产后瘀痛等。治疗胸肋疼痛、症瘕结块,以及月经不调、经闭经痛具有良效。《纲目》载:丹参,按《妇人明理论》云,四物汤治妇人病,不问产前产后,经水多少,皆可通用,惟一味丹参散,主治与之相同。盖丹参能破宿血,补新血,安生胎,落死胎,止崩中滞下,调经脉。
大血藤味苦性平,入大肠经。功用清热解毒、活血散瘀、祛风杀虫。用于肠痈腹痛、风湿痹痛、跌打伤痛,妇女痛经,赤痢,血淋,疳积虫痛等症。
赤芍味苦,微寒。归肝经。功能主治清热凉血,散瘀止痛。用于温毒发斑,吐血衄血,目赤肿痛,肝郁胁痛,经闭痛经,症瘕腹痛,跌扑损伤,痈肿疮疡。赤芍能清血分实热,散瘀血留滞。本品功能与丹皮相近,故常与丹皮相须为用。但丹皮清热凉血的作用较佳,既能清血分实热,又能治阴虚发热;而赤芍只能用于血分实热,以活血散瘀见长。
鸡血藤性苦、甘,温。归肝、肾经,补血,活血,通络。用于月经不调,血虚萎黄,麻木瘫痪,风湿痹痛活血舒筋;养血调经,《本草纲目拾遗》载其能医手足麻木;肢体瘫痪;风湿痹痛;妇女有经不调;痛经。
凌霄花一种传统中药材,具有行血去瘀、凉血祛风利湿,清热解毒,味辛酸,性微寒归肝、心包经、功能活血散瘀,凉血祛风。主治月经不调、经闭症瘕、产后乳肿、皮肤瘙痒.《本草衍义补遗》:凌霄花,治血中痛之要药也,且补阴捷甚,盖有守而独行,妇人方中多用何哉。《南宁市药物志》:有消炎解毒、止血止痛、排脓生肌之功,治红白痢。
败酱草性味苦平,具有清热解毒、排脓破瘀的功效。能医肠痈、下痢、赤白带下、产后瘀滞腹痛、目赤肿痛。入胃、大肠、肝经。主治清热解毒,消痈排脓,活血行瘀。用于肠痈、肺痈及疮痈肿毒,实热瘀滞所致的胸腹疼痛,产后瘀滞腹痛等症。
蛇床子性辛、苦,温;有小毒。归肾经。主治温肾壮阳,燥湿,祛风,杀虫。用于阳痿,宫冷,寒湿带下,湿痹腰痛;外治外阴湿疹,妇人阴痒;滴虫性阴道炎,是妇科外用良药。《本草经疏》载:蛇床子,味苦平;《别录》辛甘无毒;今详其气味,当必兼温燥,阳也。故主妇人阴中肿痛,男子阴痿湿痒,除痹气,利关节,恶疮。《别录》温中下气,令妇人子服热,男子阴强,令人有子。盖以舌能除湿,温能散寒,辛能润肾,甘能益脾,故能除妇人男子一切虚寒湿所生病。寒湿既除,则病去,性能益阳,故能已疾,而又有补益也。
地肤子性寒,味辛、苦。能清热利湿,祛风止痒。用于小便涩痛、阴痒带下、风疹、湿疹、皮肤瘙痒等症。《要药分剂》载:″入肾、膀胱二经。利小便,清湿热。治小便不利,淋病,带下,疝气,风疹,疮毒,疥癣,阴部湿痒。
青黛具有清热,凉血,解毒的功效,且性甘,平,无毒,入肝、肺、胃经。清热解毒,凉血,定惊,用于温毒发斑,血热吐衄,胸痛咳血,口疮,痄腮,据《要药分剂》载:除热解毒,兼能凉血。《雷公炮制药性解》载:“入肝,脾二经。”
蒲公英是一味常用的中药,其药用价值早已载入各种医书。它全草入药,含蒲公英甾醇、蒲公英赛醇、蒲公英苦素、咖啡酸、胆碱、菊糖等成分。性平味甘微苦。可清热解毒,消肿散结。《本草纲目》记载:“解食毒,散滞气,清热毒,化食毒,消恶肿、结核、疔肿。”蒲公英昧甘平,其性无毒。当是入肝入胃,解热凉血之要药。
穿心莲为爵床科植物穿心莲(Andrographispaniculata(Burm.f.)Nees)的全草或叶。又名春莲秋柳,一见喜,榄核莲、苦胆草、金香草、金耳钩、印度草,苦草等。味苦,性寒。归心、肺、大肠、膀胱经。有清热解毒、消炎、消肿止痛作用。主治细菌性痢疾、尿路感染、急性扁桃体炎、肠炎、咽喉炎、肺炎和流行性感冒等,外用可治疗疮疖肿毒、外伤感染等。《广西中草药》:止血凉血,拔毒生肌,治肺脓疡,口腔炎。
鸡血藤性苦、甘,温。归肝、肾经,补血,活血,通络。用于月经不调,血虚萎黄,麻木瘫痪,风湿痹痛活血舒筋;养血调经,《本草纲目拾遗》载其能医手足麻木;肢体瘫痪;风湿痹痛;妇女有经不调;痛经。外用是活血化淤的妇科良药。
覆盆子植物可入药,有多种药物价值,其果实有补肾壮阳的作用。覆盆子油属于不饱和脂肪酸,可促进前列腺分泌苛尔蒙。功效:补肝益肾,固精缩尿,明目。以大鼠、兔的阴道涂片及内膜切片作观察指标,覆盆子似有雌激素样作用。抑菌作用100%煎剂用平板打洞法,对葡萄球菌有抑制作用,对霍乱弧菌也有抑制作用。雌激素样作用大鼠、兔的阴道涂片及内膜切片等指标表明,覆盆子似有雌激素样作用。
益母草味辛苦、凉。活血、祛淤、调经、消水。治疗妇女月经不调,胎漏难产,胞衣不下,产后血晕,瘀血腹痛,崩中漏下,尿血、泻血,痈肿疮疡。益母草碱性皮下注射有中枢抑制作用,MLD为0.4-0.6g/kg。兔静脉注射益母草碱1mg/kg,可见尿量显著增加。益母草碱在较高浓度时能使兔血悬液发生溶血作用。益母草碱水浸液用试管稀释法1∶13-1∶10,对许兰氏毛菌,羊毛样小孢子菌、红色表皮癣菌、星状奴卡氏菌均有抑制作用。益母草煎剂用平板纸片法,对大肠杆菌、志贺氏痢疾杆菌有抑制作用。益母草能去淤生新,活血调经,含有硒、锰等多种微量元素,能抗氧化、防衰老,具有相当不错的益颜美容、抗衰防老功效。
黄芩有清热燥湿,凉血安胎,解毒功效。主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症。黄芩的临床应用抗菌比黄连还好,而且不产生抗药性。我们借助广谱抗菌作用强的特点,用在真菌培养杂菌感染特厉害,用黄芩提取液效果很好。《本草经疏》:黄芩,其性清肃,所以除邪:味苦所以燥湿;阴寒所以胜热,故主诸热。诸热者,邪热与遍热也,黄疸、肠僻、泄痢,皆湿热胜之病也,析其本,则诸病自瘳矣。苦寒能除湿热,所以小肠利而水自逐,源清则流洁也。血闭者,实热在血分,即热人血室,令人经闭不通,湿热解,则荣气清而自行也。恶疮疽蚀者,血热则留结,而为痈肿渍烂也:火疡者,火气伤血也,凉血除热,则自愈也。黄芩有抗变态反应及抗炎作用:黄芩所含黄芩甙与黄芩素能明显抑制致敏豚鼠离体小肠与离体气管对抗原所产生的过敏性收缩反应,对豚鼠与小鼠的被动全身性变态反应以及豚鼠被动性皮肤变态反应,黄芩甙与黄芩素亦有抑制作用。黄芩有解热作用,多数试验证明,黄芩的有效成份黄芩甙元有解热作用。黄芩有解毒作用,黄芩甙有明显的解毒作用,这可能是由于在β-葡萄糖醛酸甙酶的作用下,黄芩甙分解出葡萄糖醛酸,并与多种毒物结合所致。黄芩甙10毫克能提高士的宁的LD50达2.5倍,并且使四氯化碳中毒小鼠的肝糖原含量增多。
桑白皮为桑科植物桑MorusalbaL.的根皮。主产于安徽、河南、浙江、江苏、湖南等地。功效:泻肺平喘,利水消肿。用于肺热咳喘,面目浮肿,小便不利等症。《药性论》:使,平。能治肺气喘满,水气浮肿,主伤绝,利水道,消水气,虚劳客热头痛,内补不足。《日华子本草》:温,调中,下气。消痰止渴,利大小肠,开胃,下食,杀腹藏虫,止霍乱吐泻。
山茱萸,主治心下邪气寒热,温中,逐寒温痹,去三虫,久服轻身有强阴益精、安五脏、通九窍、止小便淋沥之功;久服明目、强力长年。山茱萸,又名山芋肉、药枣、实枣儿、枣皮、肉枣等,为我国常用名贵中药材,应用历史悠久。它以其补力平和、壮阳而不助火,滋阴而不腻膈,收敛而不留邪等特殊功效被历代医学所喜用。张仲景以山茱萸为君创制了“金匮肾气丸”。据化学分析,山茱萸含有生理活性较强的山茱萸甙、酒石酸、没食子酸、苹果酸、树酯、鞣质和多种维生素等有效成分,具有增强免疫、抗炎、抗菌等药理作用,是中医临床中常用的一味药。
白芍入肝、脾经,养血柔肝,缓中止痛,敛阴收汗。治胸腹胁肋疼痛,泻痢腹痛,自汗盗汗,阴虚发热,月经不调,崩漏,带下,妇人血闭不通,消瘀血,能蚀脓,益女子血。《日华子本草》:治风、补劳,主女人一切病,并产前后诸疾,通月水,退热,除烦,益气,天行热疾,瘟瘴,惊狂,妇人血运,及肠风,泻血,痔瘘。发背,疮疥,头痛,明目,目赤努肉。赤色者多补气,白者治血。
香附辛微苦甘,平功能主治:理气解郁,调经止痛。用于肝郁气滞,胸、胁、脘腹胀痛,消化不良,月经不调,经闭痛经,寒疝腹痛,乳房胀痛。《纲目》载其:散时气寒疫,利三焦,解六郁,消饮食积聚,痰饮痞满,跗肿,腹胀,脚气,止心腹、肢体、头、目、齿、耳诸痛,痈疽疮疡,吐血,下血,尿血,妇人崩漏带下,月候不调,胎前产后百病。
白芷性味归经:辛,温。归肺、胃经。祛风散寒,通窍止痛,消肿排脓,燥湿止带。《日华子本草》:治目赤胬肉,及补胎漏滑落,破宿血,补新血,乳痈、发背、瘰疬、肠风、痔瘘,排脓,疮痍、疥癣,止痛生肌,去面皯疵瘢。
苦参性苦,寒。归心、肝、胃、大肠、膀胱经清热燥湿,杀虫,利尿。用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风;外治霉菌性阴道炎,常与黄柏结合使用,是治疗阴道炎的外用妇科良药。
土茯苓性味:甘淡,平。归经:肝经;胃经;脾经。功能:解毒,除湿,利关节。主治:治梅毒,淋浊,筋骨挛痛,脚气,疔疗疮,痈肿,瘰疬
本发明栓剂的制备步骤为:取丹参1000g,穿心莲1000g,鸡血藤1000g,益母草1000g,桃仁1000g,败酱草1000g,大血藤1000g,赤芍1000g,凌霄花1000g,接骨木1000g,蒲公英1000g,黄芩1000g,地肤子1000g,青黛1000g,蛇床子1000g,桑白皮1000g,山茱萸1000g,覆盆子1000g,白芍1000g,苦参1000g,土茯苓1000g,加水浸泡30分钟至1小时,加热煮沸30~40分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30~40分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸30~40分钟,过滤;将三次滤液合在一起,加热浓缩至膏状,再将白芷1000g、香附1000g用水蒸汽蒸馏法提取,得结晶物,混在上述得到的药膏里;选取基质50℃~60℃加热融化,加入上述得到的药膏冷却定型制成类弹头状栓剂,紫外线杀毒。所述栓剂所用的基质选自:半合成脂肪酸甘油酯、泊洛沙姆、聚乙二醇、羊毛脂中的一种或多种;所述基质在温度50℃~60℃条件下加热融化,加入所述制备方法制得的药物膏体,水浴搅拌均匀,混合成粘稠的液体,灌注在塑料定型管内,插入棉栓,冷却定型制成子弹头状栓剂;所述棉栓为尾部带有棉线的棉栓。
本发明栓剂的制备步骤还可以为:取丹参1500g,穿心莲1500g,鸡血藤1500g,益母草1500g,桃仁1500g,败酱草1500g,大血藤1500g,赤芍1500g,凌霄花1500g,接骨木1500g,蒲公英1500g,黄芩1500g,地肤子1500g,青黛1500g,蛇床子1500g,桑白皮1500g,山茱萸1500g,覆盆子1500g,白芍1500g,苦参1500g,土茯苓1500g,将所述原料药,放入粉碎机粉碎后过100目细筛,使能通过100目筛的细粉量在达到30%,收集通过100目筛的原料细粉备用。将过筛后剩下的颗粒物放入乙醇中加热回流提取2次,每次1~2小时,将2次提取液合并静置;将上述乙醇提取过的药渣加10倍量水加热回流提取2次,每次1~2小时,将2次提取液合并静置。将香附1500g与白芷1500g蒸馏汽化得结晶,干燥成粉末;再将上述两种提取液合并,减压浓缩相对密度为80℃时1.37的滤液,回收乙醇,将所得滤液调整比重到1.06,加入过筛的细粉和结晶粉末后搅匀,倒入基质中,50℃~60℃加热融化,冷却定型制成类弹头状栓剂,所述粉剂中成药与基质的配比为1∶2~1∶4;所述棉栓为尾部带有棉线的棉栓。
本发明治疗慢性盆腔炎中药组合物,外敷药剂制成栓剂,则取基质加热融化,温度50℃~60℃,加入本发明的药细粉,水浴搅拌均匀,混合成粘稠的液体,灌注在塑料定型管内,插入棉栓,冷却定型制成类似子弹头状栓剂。一般所用基质可为:半合成脂肪酸甘油酯、羊毛脂、聚乙二醇,药细粉与基质的配比为1∶2~1∶4,优选为1∶3,或采用泊洛沙姆poloxamer作为基质,其已被广泛用作栓剂的亲水性基质,具有以下优点:比其他基质的溶解度柔和、快速,载药量也较高。
所述栓剂的具体用法如下:将本发明药物栓剂除去塑料外壳,取出药栓,拉出尾部棉线,将药栓纳入阴道深部,棉线留在体外,每晚1粒,次日晨起拉出棉栓,连续用药7天为一疗程。
以上所述,仅是本发明的较佳实施例而已,并非是对本发明作其它形式的限制,任何熟悉本专业的技术人员可能利用上述揭示的技术内容加以变更或改型为等同变化的等效实施例。但是凡是未脱离本发明技术方案内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与改型,仍属于本发明技术方案的保护范围。
Claims (2)
1.一种治疗妇科炎症的中药组合物,其特征在于,所述中药组合物中各种原料的重量份数包括:丹参10~15份,穿心莲10~15份,鸡血藤10~15份,益母草10~15份,桃仁10~15份,败酱草10~15份,大血藤10~15份,赤芍10~15份,凌霄花10~15份,接骨木10~15份,蒲公英10~15份,黄芩10~15份,地肤子10~15份,青黛10~20份,蛇床子10~20份,桑白皮10~20份,山茱萸10~20份,覆盆子10~20份,白芍10~20份,香附10~20份,白芷10~20份,苦参10~20份,土茯苓10~20份。
2.根据权利要求1所述治疗妇女慢性盆腔炎的中药栓剂,其特征在于,所述中药栓剂中各种原料的重量份数为:丹参10~15份,穿心莲10~15份,鸡血藤10~15份,益母草10~15份,桃仁10~15份,败酱草10~15份,大血藤10~15份,赤芍10~15份,凌霄花10~15份,接骨木10~15份,蒲公英10~15份,黄芩10~15份,地肤子10~15份,青黛10~15份,蛇床子10~15份,桑白皮10~15份,山茱萸10~15份,覆盆子10~15份,白芍10~15份,香附10~15份,白芷10~15份,苦参10~15份,土茯苓10~15份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510854513.3A CN105362839A (zh) | 2015-11-28 | 2015-11-28 | 一种治疗妇科炎症的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510854513.3A CN105362839A (zh) | 2015-11-28 | 2015-11-28 | 一种治疗妇科炎症的中药组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105362839A true CN105362839A (zh) | 2016-03-02 |
Family
ID=55365790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510854513.3A Pending CN105362839A (zh) | 2015-11-28 | 2015-11-28 | 一种治疗妇科炎症的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105362839A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106075218A (zh) * | 2016-07-25 | 2016-11-09 | 湖南中医药大学 | 一种直肠滴入治疗妇科疾病的中药物及其制备方法和应用 |
| CN107875329A (zh) * | 2017-06-21 | 2018-04-06 | 苏州雅致堂草本科技有限公司 | 治疗妇女慢性盆腔炎及阴道炎症的中药栓剂及其制备方法 |
| CN113813346A (zh) * | 2021-11-06 | 2021-12-21 | 张春梅 | 一种妇科外用药丸及其包裹工艺和制备方法 |
-
2015
- 2015-11-28 CN CN201510854513.3A patent/CN105362839A/zh active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106075218A (zh) * | 2016-07-25 | 2016-11-09 | 湖南中医药大学 | 一种直肠滴入治疗妇科疾病的中药物及其制备方法和应用 |
| CN107875329A (zh) * | 2017-06-21 | 2018-04-06 | 苏州雅致堂草本科技有限公司 | 治疗妇女慢性盆腔炎及阴道炎症的中药栓剂及其制备方法 |
| CN113813346A (zh) * | 2021-11-06 | 2021-12-21 | 张春梅 | 一种妇科外用药丸及其包裹工艺和制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102048894B (zh) | 一种治疗烧伤的中药组合物及其制备方法 | |
| CN101288710B (zh) | 一种治疗妇科炎症的药物 | |
| CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
| CN103721131A (zh) | 一种治疗妇女慢性盆腔炎的中药栓剂及其制备方法 | |
| CN102847063B (zh) | 一种治疗气血两虚血瘀型糖尿病足的中药组合物及其制备方法 | |
| CN102178804B (zh) | 一种治疗肛周湿疹的中药组合物及其制备方法 | |
| CN101433654B (zh) | 一种治疗妇女慢性盆腔炎的中药制剂及其制备方法 | |
| CN102205026A (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
| CN104274788A (zh) | 一种治疗妇女肝火湿热型带下的中药组合物及其制备方法 | |
| CN102178877B (zh) | 一种治疗阴囊湿疹的外用制剂及其制备方法 | |
| CN105853619A (zh) | 一种治疗湿疹的外用药膏及制备方法 | |
| CN105381352A (zh) | 一种治疗妇科炎症的外用中药洗液 | |
| CN102626505B (zh) | 基于中草药的按摩膏及其制备方法 | |
| CN100525827C (zh) | 一种内服治疗痛经中药组合物 | |
| CN105362839A (zh) | 一种治疗妇科炎症的中药组合物 | |
| CN102961483B (zh) | 一种治疗腰腿痛的中药组合物及其制备方法 | |
| CN104906465A (zh) | 一种治疗妇女慢性盆腔炎的中药化瘀组合物及其制备方法 | |
| CN104721749A (zh) | 一种治疗产褥感染后的中药清洗液及其制备方法 | |
| CN101637552B (zh) | 一种防治慢性盆腔炎的中药组合物 | |
| CN105250878A (zh) | 一种治疗亚急性感染性心内膜炎的中药 | |
| CN102940738B (zh) | 一种用于熏洗治疗痔瘘术后肛门坠胀的中药组合物 | |
| CN109432262A (zh) | 一种治疗妇科炎症的中药组合物、制剂、制备方法及其应用 | |
| CN106177639A (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
| CN105998442A (zh) | 一种治疗湿疹的外用药膏及制备方法 | |
| CN106038802A (zh) | 治疗妇女卵巢早衰的中药组合物制备方法及其组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160302 |
|
| WD01 | Invention patent application deemed withdrawn after publication |